While Sanofi’s immunology megablockbuster Dupixent predictably dominated the company’s sales charts in 2024, a new golden ...

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

Over-exposure to an allergen also raises the risk of allergies, says David Cor ry, MD, professor of medicine in the section ...

A board-certified immunologist clears the air—turns out, there's only one time when allergies can lead to a fever.

Viruses are masters at disguise. When they are pushed too far by our immune system, they send new virus variants into play ...

Dozens of Alberta scientists, doctors and researchers have penned an open letter calling on the Alberta government to reject ...

In mice with Alzheimer's, the course of menthol for a six-month-long period was enough to stop the cognitive abilities and ...

A new treatment for severe dust mite allergy has been recommended by NICE, for patients whose symptoms have not been helped ...

The human cost of the pandemic has been talked about in terms of job loss, mass migration and GDP fall, but animals have not ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed a computer model to help scientists identify tumor-fighting immune cells in ...

Zenas BioPharma, Inc.’s ZBIO share price has surged by 13.37%, which has investors questioning if this is right time to sell.

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.